NUREXONE BIOLOGIC INCNUREXONE BIOLOGIC INCNUREXONE BIOLOGIC INC

NUREXONE BIOLOGIC INC

No trades
See on Supercharts

Price target

1.900.000.00%
The 2 analysts offering 1 year price forecasts for J90 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to J90 in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


J90 EPS for the last quarter is −0.02 EUR despite the estimation of −0.03 EUR. In the next quarter EPS is expected to reach −0.02 EUR. Track more of NUREXONE BIOLOGIC INC financials and stay on top of what is up with the company.
In the next quarter NUREXONE BIOLOGIC INC revenue is expected to reach 0.00 EUR. Check out NUREXONE BIOLOGIC INC revenue and earnings and make informed decisions.
According to analysts, J90 price target is 1.90 EUR with a max estimate of 2.05 EUR and a min estimate of 1.75 EUR. Check if this forecast comes true in a year, meanwhile watch NUREXONE BIOLOGIC INC stock price chart and keep track of the current situation with J90 news and stock market news.